ID: ALA1201921

Max Phase: Preclinical

Molecular Formula: C13H20N2O6

Molecular Weight: 210.28

Molecule Type: Small molecule

Representations

Canonical SMILES:  CC(=O)N(C)CC#CCN1CCC(O)C1.O=C(O)C(=O)O

Standard InChI:  InChI=1S/C11H18N2O2.C2H2O4/c1-10(14)12(2)6-3-4-7-13-8-5-11(15)9-13;3-1(4)2(5)6/h11,15H,5-9H2,1-2H3;(H,3,4)(H,5,6)

Standard InChI Key:  OEWXPBISFMOEPB-UHFFFAOYSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 210.28

Molecular Weight (Monoisotopic): 210.1368

AlogP: -0.47

#Rotatable Bonds: 2

Polar Surface Area: 43.78

Molecular Species: NEUTRAL

HBA: 3

HBD: 1

#RO5 Violations: 0

HBA (Lipinski): 4

HBD (Lipinski): 1

#RO5 Violations (Lipinski): 0

CX Acidic pKa:

CX Basic pKa: 7.63

CX LogP: -0.83

CX LogD: -1.26

Aromatic Rings: 0

Heavy Atoms: 15

QED Weighted: 0.63

Np Likeness Score: -0.97

References

1. Bradbury BJ, Baumgold J, Paek R, Kammula U, Zimmet J, Jacobson KA..  (1991)  Muscarinic receptor binding and activation of second messengers by substituted N-methyl-N-[4-(1-azacycloalkyl)-2-butynyl]acetamides.,  34  (3): [PMID:1848294] [10.1021/jm00107a029]

Source

Source(1):

• Scientific Literature